DDX41 and hematologic disorder: DDX41 variants were identified in 34 of 716 patients (4.7%) with hematologic malignancies, including 33 patients (4.6%) with germline DDX41 variants and one with only a somatic DDX41 variant (Supplementary Tables S2 and S3).